Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Purple Biotech Ltd. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −10 vs. Q2 2024
- Shares held
- 170.4K
- +75.0K (+78.6%) vs. Q2 2024Converted for a 1-for-20 split
- Total value
- $946.1K
- +$170.2K (+21.9%) vs. Q2 2024
- New holders
- 3
- 1 more added
- Sold out
- 13
- 4 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 158,000 | $876.9K | 0.02% | +90,100+132.7% | AddedConverted for a 1-for-20 split |
| Morgan Stanley | 8,055 | $44.7K | 0.00% | −2,095−20.6% | ReducedConverted for a 1-for-20 split |
| BNP Paribas Arbitrage, SA | 3,675 | $20.4K | 0.00% | +3,675 | New |
| Tower Research Capital LLC (TRC) | 254 | $1.42K | 0.00% | +254 | New |
| TD Waterhouse Canada Inc. | 200 | $1.14K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Royal Bank of Canada | 107 | $1.00K | 0.00% | −1−0.8% | ReducedConverted for a 1-for-20 split |
| JPMorgan Chase & Co | 42 | $234 | 0.00% | −1−2.2% | ReducedConverted for a 1-for-20 split |
| Group One Trading, L.P. | 20 | $111 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Global Retirement Partners, LLC | 16 | $89 | 0.00% | −1−4.8% | ReducedConverted for a 1-for-20 split |
| North Star Investment Management Corp. | 15 | $83 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Danske Bank A/S | 4 | $22 | 0.00% | +4 | New |
| Kingswood Wealth Advisors, LLC | 0 | $0 | 0.00% | −10,403−100.0% | Sold outConverted for a 1-for-20 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,231−100.0% | Sold outConverted for a 1-for-20 split |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −1,108−100.0% | Sold outConverted for a 1-for-20 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −964−100.0% | Sold outConverted for a 1-for-20 split |
| Wealth Advisors of Iowa, LLC | 0 | $0 | 0.00% | −714−100.0% | Sold outConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −633−100.0% | Sold outConverted for a 1-for-20 split |
| UBS Group AG | 0 | $0 | 0.00% | −643−100.0% | Sold outConverted for a 1-for-20 split |
| HRT Financial LP | 0 | $0 | 0.00% | −687−100.0% | Sold outConverted for a 1-for-20 split |
| Raymond James & Associates | 0 | $0 | 0.00% | −500−100.0% | Sold outConverted for a 1-for-20 split |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold outConverted for a 1-for-20 split |
| Aviso Financial Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold outConverted for a 1-for-20 split |
| Rhumbline Advisers | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-20 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold outConverted for a 1-for-20 split |